This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Elexopharm Gmbh, Universitaet Des Saarlandes. Active years: 2013-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2018
Title: Martin Frotscher: Innovator in Hormone-Related Disease Treatment
Introduction
Martin Frotscher is a notable inventor based in Sulzbach, Germany. He has made significant contributions to the field of medicine, particularly in the development of inhibitors for hormone-related diseases. With a total of 2 patents, Frotscher's work is recognized for its potential impact on health care.
Latest Patents
Frotscher's latest patents include innovative approaches to treating hormone-related diseases. One of his patents focuses on inhibitors of 17Beta-hydroxysteroid dehydrogenases type 1 and type 2. This invention provides non-steroidal inhibitors aimed at treating and preventing hormone-related diseases. Another significant patent involves the use of non-steroidal 17beta-hydroxysteroid dehydrogenase type 1 inhibitors specifically for the treatment and prophylaxis of estrogen-dependent diseases. These inventions highlight his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Martin Frotscher has worked with esteemed institutions such as Universität des Saarlandes and Elexopharm GmbH. His experience in these organizations has contributed to his expertise in the field of hormone-related treatments.
Collaborations
Frotscher has collaborated with notable colleagues, including Rolf Wolfgang Hartmann and Sandrine Oberwinkler. These partnerships have likely enriched his research and development efforts.
Conclusion
Martin Frotscher's contributions to the field of medicine through his patents and collaborations demonstrate his dedication to improving treatments for hormone-related diseases. His innovative work continues to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile